Page 74 - Sohini Das

Top pharma firms to hike R&D spend next 5 yrs as mkt eyes $130 bn revenue

Industry captains feel pandemic has opened up opportunities for the sector in India to emerge as a second source of raw material and finished products, after China

Expand PLI scheme for pharma to make it research-linked, says industry

So far 55 drug manufacturers have been selected under the PLI scheme for pharma.

mRNA Covid vax scientist Weissman working on universal coronavirus vaccine

Universal coronavirus Vaccine: University of Pennsylvania's Perelman School of Medicine's Dr Drew Weissman are in talks with India and other countries for building mRNA production sites.

Global community can tap India's Covid vaccine capacity, say firms

Bharat Biotech MD Krishna Ella said India now has four BSL-4 containment facilities, equal to that of the UK.

Booster dose: Dose gap, natural infection slow offtake among 60-plus

Experts are also questioning the nine-month gap between the second and the third doses

India confirms first Omicron-related death as Covid-19 cases jump

As cases continued to rise across the country, several state governments were forced to issue fresh guidelines on restrictions

Molnupiravir not in national clinical protocol due to safety concerns

ICMR chief says task force has debated twice on whether to include the drug in the protocol, but decided against it

Stricter Covid-19 curbs back in India as Omicron cases multiply

Weekend curfew in Delhi; Mumbai warns of lockdown if daily cases cross 20,000

Price war rages as pharma firms despatch Covid-19 antiviral pill

Competitive pricing among firms keeps rates at Rs 1,400-2,490 for full treatment

Bharat Biotech starts re-labelling old stock after shelf life extension

After receiving the order from the Central Drugs Standard Control Organisation (CDSCO), the company started lifting unused stock from hospitals to re-label the shelf life from 9 months to 12 months

Mixing Covaxin and Covishield induces four times more antibodies: Study

The Spike-protein neutralizing antibodies found in the mixed vaccine groups were significantly higher than the same-vaccine groups

Third Covid-19 wave is here; 75% cases in metros Omicron: NTAGI's N K Arora

New variant in 81% of samples genome tested: Delhi health minister

Covid-19 pandemic: Expect a slow but steady start to teen vaccination

Day 1 to see a few hundred shots administered at most sites

Hospital sector could grow at 18% when Covid ends: Manipal Hospitals CEO

The Omicron situation is still evolving but the early signs are ominous, says Jose

Indian drugmakers get close to nod for Merck's Covid antiviral Molnupiravir

The significance of the Molnupiravir approval is that it could offer an affordable oral drug to treat Covid-19, and may even be effective against the Omicron variant

Action on Omicron: Step up testing to spot new variant, says govt

The health ministry also asked states to make sure testing of international passengers is done on the first and the eighth day scrupulously

Companies gear up for Omicron version of coronavirus vaccines

Zydus to keep a laboratory product ready based on the new variant

Bharat Biotech's Covaxin set to go global after WHO gives it a booster

Becomes sixth vaccine to receive validation; move will ease foreign travel for those who got jab

WHO grants much-awaited emergency use listing to Bharat Biotech's Covaxin

Move will ease international travel for those vaccinated with the jab

Zydus Cadila testing a multi-variant Covid-19 vaccine on animals

Mixing multiple strains to get what is called a multi-variant vaccine may be a way to get better immunity, scientists feel